reports
StepStone Group Announces 2025 Partner and Managing Director Promotion...
StepStone Group Announces 2025 Partner and Managing Director Promotions NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, has named 10 new partners and 24 new managing directors. Partner and CEO Scott Hart said, “The momentum of the StepStone franchise is as strong as ever, which is a testament to the great talent we have attracted, cultivated, and promoted into leadership positions over the years. Congratulations to the newest clas...
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conferen...
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025 NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that the Company will participate in multiple sessions at the (IO360°) Conference 2025, held March 24-26, 2025, in Boston, MA. William Ho, Chief Executive Officer and co-founder of IN8bio, will be Co-Chairing Day 2 of the conference starting at 8:15 AM EDT on March 25, 2025. He will deliver the welcom...
Foresight Announces the Integration of NVIDIA Jetson Orin into its 3D ...
Foresight Announces the Integration of NVIDIA Jetson Orin into its 3D Perception Systems Foresight to equip autonomous drones and unmanned aerial vehicles with NVIDIA Jetson Orin platform for enhanced real-time perception, obstacle detection, and energy efficiency across diverse applications NESS ZIONA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), a leading innovator in 3D perception systems, announces the integration of computing platforms into its cutting-edge perception technologies. The collabo...
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Appr...
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema OCU200 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reportedDosing of the second cohort has been approved MALVERN, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Data and Safety Monitoring Board (DSMB...
DIRTT Receives Top Honor in Manufacturing on Fast Company’s Annual Lis...
DIRTT Receives Top Honor in Manufacturing on Fast Company’s Annual List of the World’s Most Innovative Companies of 2025 CALGARY, Alberta, March 18, 2025 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (TSX: DRT) (OTC: DRTTF) (“DIRTT”), a leader in industrialized construction, has been named number one in Manufacturing on Fast Company’s prestigious list of the . The list highlights companies that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy. “With a vision to transform how the world ...
Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizab...
Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board NEEDHAM, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Elizabeth M. Jaffee, M.D., to the Company's Research Advisory Board (RAB). Dr. Jaffee, an internationally recognized expert in cancer immunology and pancreatic cancer, brings her extensive ex...
Nuvini Group Announces Term Sheet for the Acquisition of B2B SaaS Plat...
Nuvini Group Announces Term Sheet for the Acquisition of B2B SaaS Platform Munddi ~ Strengthens Portfolio with Strategic Expansion in Latin America ~ ~ First of Four Anticipated Acquisitions in 2025 ~ NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private B2B SaaS companies in Latin America, today announced that it has entered into a term sheet (the “Term Sheet”) for the acquisition of Munddi Soluções em Tecnologia Ltda. – ME (“Munddi”), an online platform that connects brands with consumers, suppliers,...
Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Ra...
Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Radoff and Michael Torok PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that it has entered into a letter agreement (the “Letter Agreement”) with Bradley L. Radoff and Michael Torok (collectively with their affiliates, the “Radoff/Torok Group”), under which the Radoff/Torok Group has agreed that during the period commencing on the date of the Letter Agreement until th...
CURRENC to Develop 500MW Hyperscale AI Data Center in Malaysia
CURRENC to Develop 500MW Hyperscale AI Data Center in Malaysia Groundbreaking Infrastructure Project Propelling Global Financial Institutions’ AI Innovation SINGAPORE, March 18, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced plans to acquire 100 acres of land in Johor, Malaysia, to build a hyperscale Artificial Intelligence Data Center (AIDC). Featuring a total planned capacity of 500MW, the 100-acre AIDC campus will be dev...
How Agents are Accelerating Enterprise-Wide Transformation: UiPath to ...
NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a leading software company, today announced its annual will take place online on March 25, offering attendees deeper insight into the latest UiPath agentic automation innovations and strategies for implementing agentic AI and automation to deliver consistent, reliable, and transformative business outcomes. Agentic automation integrates AI agents, robots, and people to streamline operations, automate complex end-to-end business processes with multiple workflows and contextual decision-making, improve scalability, and unlock new levels of produ...
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursd...
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025 GREENWICH, Conn., March 18, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20, 2025. The symposium will draw a variety of companies, with a focus on pricing power, margin recovery, interest rates, inventory stabilization, global trade policy, demand trends, and the M&A environment. Attendees will also have the opportunity to meet with managements in a one-on-one setting. Ag...
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 F...
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results PRINCETON, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company will host a conference call to report financial results for the year ended December 31, 2024, and provide a clinical programs update on Thursday, March 27, 2025, at 8:00 a.m. Eastern Time. Conference Call Details Date: March 27, 2...
Cidara Therapeutics Announces Two Presentations on CD388 in Influenza ...
Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025 SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming presentations at the 38th International Conference on Antiviral Research (ICAR). The conference takes place from March 17-21, 2025 in Las Vegas, Nevada. Cidara’s presentations will highlight the study design, demographic inform...
Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financi...
Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025 CAMBRIDGE, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, and provide a business update, on March 27, 2025. Management w...
Recursion Bolsters Board of Directors with Former FDA Principal Deputy...
Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun Dr. Bumpus brings deep experience in scientific innovation and regulatory strategy, while Elaine Sun adds extensive leadership in life sciences finance and corporate strategy. Salt Lake City, UT, March 18, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that Namandjé Bumpus, Ph.D, and Elaine Sun have been appointed to Recursion’s Board of Direc...
TSA PreCheck® Enrollment Pop-up Events at the ItsEasy.com Offices in t...
TSA PreCheck® Enrollment Pop-up Events at the ItsEasy.com Offices in the Iconic NYC Locations: The MetLife Building and Rockefeller Center ItsEasy.com and Telos Corporation announce new TSA PreCheck enrollment pop-up events, reinforcing their commitment to making travel as easy and convenient as possible. NEW YORK and ASHBURN, Va., March 18, 2025 (GLOBE NEWSWIRE) -- Passport & Visa Services, the leading passport and visa expediting company that has processed over 2 million passport and visa applications, and (NASDAQ: TLS), an authorized TSA PreCheck® enrollment provider, today announc...
REE Automotive Signs MOU for Software-Defined Technology with One of T...
REE Automotive Signs MOU for Software-Defined Technology with One of The Leading Technology Companies, Paving the Way Toward Multi-Year, Large-Volume Autonomous Vehicles Framework Agreement REE is intended to be the exclusive provider of software-defined vehicle technology to this leading tech company in multiple global marketsDefinitive long-term collaboration agreement expected in 2025, leveraging REE's P7 platform to deliver thousands of autonomous vehicles by 2030 with start of production expected in 2027Targeting revenue from the strategic collaboration agreement of up to $770 million ...
MicroCloud Hologram Inc. Utilizes Matrix Product States to Achieve Hig...
MicroCloud Hologram Inc. Utilizes Matrix Product States to Achieve High-Precision Quantum State Preparation with Mirror-Symmetric Probability Distribution SHENZHEN, China, March 18, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, announced the proposal of a new method based on Matrix Product States (MPS) that enables high-precision quantum state preparation with a mirror-symmetric probability distribution. This research not only reduces the entanglement of the probability distribution but also significantly improv...
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of...
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in MDD subjects ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major...
Beyond Announces Sale of Majority stake in Zulily Brand
Beyond Announces Sale of Majority stake in Zulily Brand Sale of 75% of brand at approximately $6.7 million-dollar valuation allows company to achieve return on investment and accelerate our core brands path to profitability MURRAY, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Beyond, Inc. (NYSE:BYON), owner of Bed Bath & Beyond, buybuy BABY and Overstock announced today that it has entered into a definitive agreement to sell its Zulily brand to Lyons Trading Company, the operator of leading online off-price retailer Proozy.com. Beyond will receive $5 million while maintaining a 25% stake in...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.